These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8511439)

  • 1. Use of backcalculation for estimation of the probability of progression from HIV infection to AIDS.
    Marion SA; Schechter MT
    Stat Med; 1993 Apr; 12(7):617-31. PubMed ID: 8511439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How many persons in Canada have been infected with human immunodeficiency virus? An exploration using backcalculation methods.
    Schechter MT; Marion SA; Elmslie KD; Ricketts M
    Clin Invest Med; 1992 Aug; 15(4):331-45. PubMed ID: 1516290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertainty in estimates of HIV prevalence derived by backcalculation.
    Rosenberg PS; Gail MH
    Ann Epidemiol; 1990 Dec; 1(2):105-15. PubMed ID: 1669493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of estimates of the AIDS incubation distribution.
    Cooley PC; Myers LE; Hamill DN
    Eur J Epidemiol; 1996 Jun; 12(3):229-35. PubMed ID: 8884188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection/AIDS in the United States during the 1990s.
    Biggar RJ; Rosenberg PS
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S219-23. PubMed ID: 8399920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An empirical Bayes approach to the estimation of the incidence curve of HIV infection.
    Commenges D; Etcheverry B
    Stat Med; 1993 Jul; 12(14):1317-24. PubMed ID: 8210828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An empirical Bayes approach to smoothing in backcalculation of HIV infection rates.
    Liao J; Brookmeyer R
    Biometrics; 1995 Jun; 51(2):579-88. PubMed ID: 7662847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating HIV prevalence and projecting AIDS incidence in the United States: a model that accounts for therapy and changes in the surveillance definition of AIDS.
    Rosenberg PS; Gail MH; Carroll RJ
    Stat Med; 1992 Sep; 11(13):1633-55. PubMed ID: 1485051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multistate approach for estimating the incidence of human immunodeficiency virus by using HIV and AIDS French surveillance data.
    Sommen C; Alioum A; Commenges D
    Stat Med; 2009 May; 28(11):1554-68. PubMed ID: 19278012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS: the statistical basis for public health.
    De Angelis D; Day NE; Gore SM; Gilks WR; McGee MA
    Stat Methods Med Res; 1993; 2(1):75-91. PubMed ID: 8261251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia.
    Rosenberg PS; Levy ME; Brundage JF; Petersen LR; Karon JM; Fears TR; Gardner LI; Gail MH; Goedert JJ; Blattner WA
    JAMA; 1992 Jul 22-29; 268(4):495-503. PubMed ID: 1619741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What percentage of the Cuban HIV-AIDS epidemic is known?
    de Arazoza H; Lounes R; Pérez J; Hoang T
    Rev Cubana Med Trop; 2003; 55(1):30-7. PubMed ID: 15849950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the human immunodeficiency virus infection curve of intravenous drug users in Lombardia, Italy.
    Salvaggio A
    Eur J Epidemiol; 1995 Apr; 11(2):127-31. PubMed ID: 7672064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity analyses for the backcalculation method of AIDS projections.
    Wilson SR; Fazekas de St Groth C; Solomon PJ
    J Acquir Immune Defic Syndr (1988); 1992; 5(5):523-7. PubMed ID: 1560350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Backcalculation of the number infected with human immunodeficiency virus in Germany.
    Seydel J; Krämer A; Rosenberg PS; Wittkowski KM; Gail MH
    J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):74-8. PubMed ID: 8263756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Backcalculation models of age-specific HIV incidence rates.
    Rosenberg PS
    Stat Med; 1994 Oct 15-30; 13(19-20):1975-90. PubMed ID: 7846404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parametric modelling of survival following HIV and AIDS in the era of highly active antiretroviral therapy: data from Australia.
    Nakhaee F; Law M
    East Mediterr Health J; 2011 Mar; 17(3):231-7. PubMed ID: 21735964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the incubation period of paediatric AIDS in Rwanda.
    Commenges D; Alioum A; Lepage P; Van de Perre P; Msellati P; Dabis F
    AIDS; 1992 Dec; 6(12):1515-20. PubMed ID: 1492934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study.
    Stein DS; Graham NM; Park LP; Hoover DR; Phair JP; Detels R; Ho M; Saah AJ
    Ann Intern Med; 1994 Jul; 121(2):100-8. PubMed ID: 8017721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Median time from seroconversion to AIDS in Italian HIV-positive haemophiliacs: different parametric estimates.
    Chiarotti F; Palombi M; Schinaia N; Ghirardini A; Bellocco R
    Stat Med; 1994 Jan; 13(2):163-75. PubMed ID: 8122052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.